ReShape Lifesciences Inc. (NASDAQ:RSLS) Short Interest Update

ReShape Lifesciences Inc. (NASDAQ:RSLS) was the target of a significant decline in short interest in January. As of January 15th, there was short interest totalling 18,500 shares, a decline of 38.1% from the December 31st total of 29,900 shares. Currently, 2.7% of the company’s shares are short sold. Based on an average daily volume of 84,300 shares, the days-to-cover ratio is currently 0.2 days.

ReShape Lifesciences Price Performance

Shares of NASDAQ:RSLS traded up $0.18 during trading on Wednesday, reaching $3.83. 50,814 shares of the stock were exchanged, compared to its average volume of 27,466. The stock has a fifty day moving average of $4.82 and a two-hundred day moving average of $6.97. ReShape Lifesciences has a 1-year low of $3.50 and a 1-year high of $29.00.

ReShape Lifesciences Company Profile

ReShape Lifesciences Inc provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus.